Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Brain Volume Loss during the First Year of Interferon-Beta Treatment: Baseline Inflammation and Tissue-Specific Volume Dynamics.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Study hints of rituximab MS benefit
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-β to glatiramer acetate: the Escala Study.
National Cancer Institute Search for Clinical Trials
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
CHMP adopts positive opinion for PLEGRIDY™ (peginterferon beta-1a) as a treatment for multiple sclerosis in the European Union
Roche reports positive studies of MabThera given by subcutaneous injection
IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination.
New Tysabri data reaffirm substantial efficacy in treatment of people with MS and demonstrate stability of anti-JCV antibody status
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Drug Safety Labeling Changes
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Mitoxantrone-induced suicidal erythrocyte death.

Pages